Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy vs Observation in Oligometastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
J. Clin. Oncol 2022 Aug 24;[EPub Ahead of Print], MP Deek, K Van der Eecken, P Sutera, RA Deek, V Fonteyne, AA Mendes, K Decaestecker, AP Kiess, N Lumen, R Phillips, A De Bruycker, M Mishra, Z Rana, J Molitoris, B Lambert, L Delrue, H Wang, K Lowe, S Verbeke, J Van Dorpe, R Bultijnck, G Villeirs, K De Man, F Ameye, DY Song, T DeWeese, CJ Paller, FY Feng, A Wyatt, KJ Pienta, M Diehn, SM Bentzen, S Joniau, F Vanhaverbeke, G De Meerleer, ES Antonarakis, TL Lotan, A Berlin, S Siva, P Ost, PT TranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.